Similar Papers

Paper Title
Journal
Date
Author
Incidence of postoperative complications in Chinese patients with gastric or colorectal cancer based on a national, multicenter, prospective, cohort study
B W Huo ... Z Y Li
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery | VOL. 27
B W Huo, et. al.B W Huo ... Z Y Li
25 Mar 2024
The Prognostic Role of Glycemia in Patients With Pancreatic Carcinoma: A Systematic Review and Meta-Analysis.
Xiaofang Wang ... Mingming Zhang
Frontiers in oncology | VOL. 12
Xiaofang Wang, et. al.Xiaofang Wang ... Mingming Zhang
10 Feb 2022
Risk factor analysis on early postoperative complications after pancreaticoduodenectomy
...
-
, et. al. ...
15 Feb 2012
Acil Abdominal Cerrahi Yapılan COVID-19 Hastalarında Postoperatif Komplikasyonların Öngördürücüleri
Çağrı Büyükkasap ... Yunushan Furkan Aydoğdu
Turkish Journal of Clinics and Laboratory | VOL. 15
Çağrı Büyükkasap, et. al.Çağrı Büyükkasap ... Yunushan Furkan Aydoğdu
28 Mar 2024
View more papers

More From: Oncology Letters

Paper Title
Journal
Date
Author
Difficulties in the diagnosis and treatment of axillary malignant triton tumors: A case report
Yanhua Zhou ... Dongning Huang
Oncology Letters | VOL. 29
Yanhua Zhou, et. al.Yanhua Zhou ... Dongning Huang
20 Jan 2025
Retracted] Paclitaxel induces apoptosis and reduces proliferation by targeting epidermal growth factor receptor signaling pathway in oral cavity squamous cell carcinoma
Jing Hu ... Guang Li
Oncology Letters | VOL. 29
Jing Hu, et. al.Jing Hu ... Guang Li
20 Jan 2025
Sequential immunotherapy and bevacizumab treatments in glioblastoma multiforme: A case series and review of the literature
Neyran Kertmen ... Gozde Yazici
Oncology Letters | VOL. -
Neyran Kertmen, et. al.Neyran Kertmen ... Gozde Yazici
17 Jan 2025
Overexpression of miR‑424‑5p reduces cisplatin resistance by downregulating SMURF1 in gastric cancer
Daohan Wang ... Li Lu
Oncology Letters | VOL. 29
Daohan Wang, et. al.Daohan Wang ... Li Lu
15 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.